Skip to content
VLOCMarket desk
Switch to dark mode

하스

450330KOSDAQView the 제약 sectorTheme Bio & healthcare

4,125KRWMarket close of 10/28 (Wed)

Up +0.73%+30KRWMarket close of 10/28 (Wed)

Open
4,095
High
4,155
Low
4,040
Day range
Day range low 4,040 high 4,155, open 4,095, close 4,125, previous close 4,095
Volume
0×10K shares
6.92 million KRW 0.15× the 20-session average

Market close of 10/28 (Wed)

Where it sits in the 1-year range

1-year close range 3,790 to 7,800 won, 8% up from the low

8% of the way up from the lowest close in 1 year (252 sessions) · -47.1% from the high

Something to check

1 to check: operating loss

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/28 (Wed)
Market close data of 2026-10-28

Points to check

  • Earningsto check-798.43 million KRWOperating income over the last four quarters -798.43 million KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 2 are within the usual range

  • Daily move+0.73%usual range
  • Trading value0.2×usual range
See the full check report

Quarterly results · Q2 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue4.1B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -10.6%
    vs. prior quarter
    +24.1%
  • Operating income-615.14 million KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Turned to loss
    vs. prior quarter
    Still a loss
  • Operating margin-14.9%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -35.8 pp
    vs. prior quarter
    +9.7 pp

Quarterly operating income trend

As of the latest official close · 2026-10-28Valuation filing date · 2026-08-13
2024Q2 107.94 million KRW2026Q2 -615.14 million KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Up +0.44%

· 100 of 169 stocks up, preferred shares excluded · trading value 566.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +6.1%Up +0.64%80.0B KRW
삼성바이오로직스Close over the last 20 sessions -0.9%Down -0.15%68.9B KRW
파마리서치Close over the last 20 sessions -27.8%Down -1.30%43.9B KRW
한미약품Close over the last 20 sessions -27.1%Up +5.42%42.3B KRW
삼익제약Close over the last 20 sessions -13.1%Up +9.54%34.5B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 18 days
  • Next data 10/30 (Fri) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.